Key points are not available for this paper at this time.
Controversy continues to roil around the role of PSA screening in prostate cancer. The authors review the available data and its quality and conclude that the evidence does not indicate that the benefits outweigh the harms.
Pinsky et al. (Wed,) studied this question.